                         SEQUENCE LISTING

<110>  The Regents of the University of California
       Flores, Juan
 
<120>  TSPAN 33 is a Candidate for Antibody Targeted Therapy for the 
       Treatment of B Cell Hodgkin Lymphomas

<130>  1279-582-XPC

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  283
<212>  PRT
<213>  Homo sapiens

<400>  1

Met Ala Arg Arg Pro Arg Ala Pro Ala Ala Ser Gly Glu Glu Phe Ser 
1               5                   10                  15      


Phe Val Ser Pro Leu Val Lys Tyr Leu Leu Phe Phe Phe Asn Met Leu 
            20                  25                  30          


Phe Trp Val Ile Ser Met Val Met Val Ala Val Gly Val Tyr Ala Arg 
        35                  40                  45              


Leu Met Lys His Ala Glu Ala Ala Leu Ala Cys Leu Ala Val Asp Pro 
    50                  55                  60                  


Ala Ile Leu Leu Ile Val Val Gly Val Leu Met Phe Leu Leu Thr Phe 
65                  70                  75                  80  


Cys Gly Cys Ile Gly Ser Leu Arg Glu Asn Ile Cys Leu Leu Gln Thr 
                85                  90                  95      


Phe Ser Leu Cys Leu Thr Ala Val Phe Leu Leu Gln Leu Ala Ala Gly 
            100                 105                 110         


Ile Leu Gly Phe Val Phe Ser Asp Lys Ala Arg Gly Lys Val Ser Glu 
        115                 120                 125             


Ile Ile Asn Asn Ala Ile Val His Tyr Arg Asp Asp Leu Asp Leu Gln 
    130                 135                 140                 


Asn Leu Ile Asp Phe Gly Gln Lys Lys Phe Ser Cys Cys Gly Gly Ile 
145                 150                 155                 160 


Ser Tyr Lys Asp Trp Ser Gln Asn Met Tyr Phe Asn Cys Ser Glu Asp 
                165                 170                 175     


Asn Pro Ser Arg Glu Arg Cys Ser Val Pro Tyr Ser Cys Cys Leu Pro 
            180                 185                 190         


Thr Pro Asp Gln Ala Val Ile Asn Thr Met Cys Gly Gln Gly Met Gln 
        195                 200                 205             


Ala Phe Asp Tyr Leu Glu Ala Ser Lys Val Ile Tyr Thr Asn Gly Cys 
    210                 215                 220                 


Ile Asp Lys Leu Val Asn Trp Ile His Ser Asn Leu Phe Leu Leu Gly 
225                 230                 235                 240 


Gly Val Ala Leu Gly Leu Ala Ile Pro Gln Leu Val Gly Ile Leu Leu 
                245                 250                 255     


Ser Gln Ile Leu Val Asn Gln Ile Lys Asp Gln Ile Lys Leu Gln Leu 
            260                 265                 270         


Tyr Asn Gln Gln His Arg Ala Asp Pro Trp Tyr 
        275                 280             


<210>  2
<211>  283
<212>  PRT
<213>  Mus musculus

<400>  2

Met Ala Arg Arg Pro Gly Val Pro Ala Ala Tyr Gly Asp Glu Phe Ser 
1               5                   10                  15      


Phe Val Ser Pro Leu Val Lys Tyr Leu Leu Phe Phe Phe Asn Met Leu 
            20                  25                  30          


Phe Trp Val Ile Ser Met Val Met Val Ala Val Gly Val Tyr Ala Arg 
        35                  40                  45              


Leu Met Lys His Ala Glu Ala Ala Leu Ala Cys Leu Ala Val Asp Pro 
    50                  55                  60                  


Ala Ile Leu Leu Ile Val Val Gly Val Leu Met Phe Leu Leu Thr Phe 
65                  70                  75                  80  


Cys Gly Cys Ile Gly Ser Leu Arg Glu Asn Ile Cys Leu Leu Gln Thr 
                85                  90                  95      


Phe Ser Leu Cys Leu Thr Ile Val Phe Leu Leu Gln Leu Ala Ala Gly 
            100                 105                 110         


Ile Leu Gly Phe Val Phe Ser Asp Lys Ala Arg Gly Lys Val Ser Glu 
        115                 120                 125             


Ile Ile Asn Asn Ala Ile Val His Tyr Arg Asp Asp Leu Asp Leu Gln 
    130                 135                 140                 


Asn Leu Ile Asp Phe Gly Gln Lys Lys Phe Ser Cys Cys Gly Gly Ile 
145                 150                 155                 160 


Ser Tyr Arg Asp Trp Ser Gln Asn Met Tyr Phe Asn Cys Ser Glu Asp 
                165                 170                 175     


Asn Pro Ser Arg Glu Arg Cys Ser Val Pro Tyr Ser Cys Cys Leu Pro 
            180                 185                 190         


Thr Pro Asn Gln Ala Val Ile Asn Thr Met Cys Gly Gln Gly Met Gln 
        195                 200                 205             


Ala Leu Asp Tyr Leu Glu Ala Ser Lys Val Ile Tyr Thr Asn Gly Cys 
    210                 215                 220                 


Ile Asp Lys Leu Val Asn Trp Ile His Ser Asn Leu Phe Leu Leu Gly 
225                 230                 235                 240 


Gly Val Ala Leu Gly Leu Ala Ile Pro Gln Leu Val Gly Ile Leu Leu 
                245                 250                 255     


Ser Gln Val Leu Val Asn Gln Ile Lys Asp Gln Ile Lys Leu Gln Leu 
            260                 265                 270         


Tyr Asn Gln Gln His Arg Ala Asp Pro Trp Tyr 
        275                 280             


<210>  3
<211>  274
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Consensus sequence

<400>  3

Met Ala Arg Arg Pro Pro Ala Ala Gly Glu Phe Ser Phe Val Ser Pro 
1               5                   10                  15      


Leu Val Lys Tyr Leu Leu Phe Phe Phe Asn Met Leu Phe Trp Val Ile 
            20                  25                  30          


Ser Met Val Met Val Ala Val Gly Val Tyr Ala Arg Leu Met Lys His 
        35                  40                  45              


Ala Glu Ala Ala Leu Ala Cys Leu Ala Val Asp Pro Ala Ile Leu Leu 
    50                  55                  60                  


Ile Val Val Gly Val Leu Met Phe Leu Leu Thr Phe Cys Gly Cys Ile 
65                  70                  75                  80  


Gly Ser Leu Arg Glu Asn Ile Cys Leu Leu Gln Thr Phe Ser Leu Cys 
                85                  90                  95      


Leu Thr Val Phe Leu Leu Gln Leu Ala Ala Gly Ile Leu Gly Phe Val 
            100                 105                 110         


Phe Ser Asp Lys Ala Arg Gly Lys Val Ser Glu Ile Ile Asn Asn Ala 
        115                 120                 125             


Ile Val His Tyr Arg Asp Asp Leu Asp Leu Gln Asn Leu Ile Asp Phe 
    130                 135                 140                 


Gly Gln Lys Lys Phe Ser Cys Cys Gly Gly Ile Ser Tyr Asp Trp Ser 
145                 150                 155                 160 


Gln Asn Met Tyr Phe Asn Cys Ser Glu Asp Asn Pro Ser Arg Glu Arg 
                165                 170                 175     


Cys Ser Val Pro Tyr Ser Cys Cys Leu Pro Thr Pro Gln Ala Val Ile 
            180                 185                 190         


Asn Thr Met Cys Gly Gln Gly Met Gln Ala Asp Tyr Leu Glu Ala Ser 
        195                 200                 205             


Lys Val Ile Tyr Thr Asn Gly Cys Ile Asp Lys Leu Val Asn Trp Ile 
    210                 215                 220                 


His Ser Asn Leu Phe Leu Leu Gly Gly Val Ala Leu Gly Leu Ala Ile 
225                 230                 235                 240 


Pro Gln Leu Val Gly Ile Leu Leu Ser Gln Leu Val Asn Gln Ile Lys 
                245                 250                 255     


Asp Gln Ile Lys Leu Gln Leu Tyr Asn Gln Gln His Arg Ala Asp Pro 
            260                 265                 270         


Trp Tyr 
        


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  tspan33 forward primer

<400>  4
caacatgctc ttctgggtga                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  tspan33 reverse primer

<400>  5
attagccgag cgtagacacc                                                   20


<210>  6
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CD20 forward primer

<400>  6
aacaaaatct ctactttgat ggaactt                                           27


<210>  7
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  CD20 reverse primer

<400>  7
gcaaggccta ctgctgagtt                                                   20


